MedTrace Logo

Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients

NCT04186208 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2025-05-14

No results posted yet for this study

Summary

Prospective, multicenter, single-arm non-interventional study to evaluate the efficacy, safety and health economics of NOVOCART 3D in the Treatment fo cartilage defects of the knee in pediatric patients wieh closed epiphyseal growth plates.

Conditions

  • Cartilage Disease

Interventions

DRUG

NOVOCART 3D

Autologous Chondrocyte Implantation

Sponsors & Collaborators

  • Aesculap AG

    collaborator INDUSTRY

  • Winicker Norimed GmbH

    collaborator INDUSTRY

  • Tetec AG

    lead INDUSTRY

Principal Investigators

  • Peter Angele, Prof. MD · Universitätsklinikum Regensburg

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-25
Primary Completion
2023-06-14
Completion
2026-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04186208 on ClinicalTrials.gov